22 related articles for article (PubMed ID: 34090013)
1. PSGL-1 Is a T Cell Intrinsic Inhibitor That Regulates Effector and Memory Differentiation and Responses During Viral Infection.
Tinoco R; Neubert EN; Stairiker CJ; Henriquez ML; Bradley LM
Front Immunol; 2021; 12():677824. PubMed ID: 34326837
[TBL] [Abstract][Full Text] [Related]
2. Apoptosis-mediated ADAM10 activation removes a mucin barrier promoting T cell efferocytosis.
Drexhage LZ; Zhang S; Dupont M; Ragaller F; Sjule E; Cabezas-Caballero J; Deimel LP; Robertson H; Russell RA; Dushek O; Sezgin E; Karaji N; Sattentau QJ
Nat Commun; 2024 Jan; 15(1):541. PubMed ID: 38225245
[TBL] [Abstract][Full Text] [Related]
3. Nanoscopic Characterization of Cell Migration under Flow Using Optical and Electron Microscopy.
Alghamdi A; Tamra A; Rakhmatulina A; Nozue S; Al-Amoodi AS; Aldehaiman MM; Isaioglou I; Merzaban JS; Habuchi S
Anal Chem; 2023 Jan; 95(3):1958-66. PubMed ID: 36627105
[TBL] [Abstract][Full Text] [Related]
4. Nanoparticles of a New Small-Molecule P-Selectin Inhibitor Attenuate Thrombosis, Inflammation, and Tumor Growth in Two Animal Models.
Feng Q; Wang M; Muhtar E; Wang Y; Zhu H
Int J Nanomedicine; 2021; 16():5777-5795. PubMed ID: 34471352
[TBL] [Abstract][Full Text] [Related]
5. Antibody targeting of surface P-selectin glycoprotein ligand 1 leads to lymphoma apoptosis and tumorigenesis inhibition.
Pereira JL; Ferreira F; Dos Santos NR
Hematol Oncol; 2024 Mar; 42(2):e3257. PubMed ID: 38415859
[TBL] [Abstract][Full Text] [Related]
6. A novel P-selectin glycoprotein ligand-1 monoclonal antibody recognizes an epitope within the tyrosine sulfate motif of human PSGL-1 and blocks recognition of both P- and L-selectin.
Snapp KR; Ding H; Atkins K; Warnke R; Luscinskas FW; Kansas GS
Blood; 1998 Jan; 91(1):154-64. PubMed ID: 9414280
[TBL] [Abstract][Full Text] [Related]
7. Mouse P-selectin glycoprotein ligand-1: molecular cloning, chromosomal localization, and expression of a functional P-selectin receptor.
Yang J; Galipeau J; Kozak CA; Furie BC; Furie B
Blood; 1996 May; 87(10):4176-86. PubMed ID: 8639776
[TBL] [Abstract][Full Text] [Related]
8. Interaction of the selectin ligand PSGL-1 with chemokines CCL21 and CCL19 facilitates efficient homing of T cells to secondary lymphoid organs.
Veerman KM; Williams MJ; Uchimura K; Singer MS; Merzaban JS; Naus S; Carlow DA; Owen P; Rivera-Nieves J; Rosen SD; Ziltener HJ
Nat Immunol; 2007 May; 8(5):532-9. PubMed ID: 17401367
[TBL] [Abstract][Full Text] [Related]
9. P-selectin glycoprotein ligand-1 mediates L-selectin-independent leukocyte rolling in high endothelial venules of peripheral lymph nodes.
Harakawa N; Shigeta A; Wato M; Merrill-Skoloff G; Furie BC; Furie B; Okazaki T; Domae N; Miyasaka M; Hirata T
Int Immunol; 2007 Mar; 19(3):321-9. PubMed ID: 17267415
[TBL] [Abstract][Full Text] [Related]
10. P-selectin glycoprotein ligand 1 promotes T cell lymphoma development and dissemination.
Pereira JL; Cavaco P; da Silva RC; Pacheco-Leyva I; Mereiter S; Pinto R; Reis CA; Dos Santos NR
Transl Oncol; 2021 Aug; 14(8):101125. PubMed ID: 34090013
[TBL] [Abstract][Full Text] [Related]
11. PSGL-1 function in immunity and steady state homeostasis.
Carlow DA; Gossens K; Naus S; Veerman KM; Seo W; Ziltener HJ
Immunol Rev; 2009 Jul; 230(1):75-96. PubMed ID: 19594630
[TBL] [Abstract][Full Text] [Related]
12. PSGL-1, a Strategic Biomarker for Pathological Conditions in HIV Infection: A Hypothesis Review.
Zaongo SD; Chen Y
Viruses; 2023 Oct; 15(11):. PubMed ID: 38005875
[TBL] [Abstract][Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]